The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 343:208-210 July 20, 2000 Number 3
NextNext

Neonatal Group B Streptococcal Disease — Screening and Prevention

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
During the 1990s, the incidence of disease caused by mother-to-child transmission of group B streptococcus fell by 65 percent, from 1.7 to 0.6 case per 1000 live births.1 The decline stemmed from the increased use of penicillin during labor in women at high risk for transmitting the infection to their newborns. Given this striking reduction in incidence, where do we go from here?

Group B streptococcus became the leading cause of life-threatening infections in newborns during the 1970s. One woman in five is colonized with group B streptococcus in the gastrointestinal or genital tract. Infants become ill through aspiration of . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.